Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

[1]  I. Tan,et al.  High‐dose superselective intra‐arterial cisplatin and concomitant radiation (radplat) for advanced head and neck cancer , 2004, Head & neck.

[2]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[3]  N. Lee,et al.  Intensity-modulated radiation therapy for head and neck cancer , 2004, Current treatment options in oncology.

[4]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  A. Garden,et al.  Preliminary results of intensity modulated radiation therapy for small primary oropharyngeal carcinoma , 2003 .

[6]  P. Xia,et al.  Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. , 2003, International journal of radiation oncology, biology, physics.

[7]  P. Easton,et al.  Geniohyoid muscle function in awake canines. , 2003, Journal of applied physiology.

[8]  D. Paydarfar,et al.  Sensory Regulation of Swallowing and Airway Protection: A Role for the Internal Superior Laryngeal Nerve in Humans , 2003, The Journal of physiology.

[9]  Jan J W Lagendijk,et al.  Intrafraction motions of the larynx during radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[10]  S. Cha,et al.  Swallow Function in Patients Before and After Intra‐Arterial Chemoradiation , 2003, The Laryngoscope.

[11]  Daniel A Low,et al.  Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. , 2003, International journal of radiation oncology, biology, physics.

[12]  A. Rademaker,et al.  Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Bourhis,et al.  Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. , 2002, Seminars in oncology.

[14]  N. Senzer.  A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings. , 2002, Seminars in oncology.

[15]  J. Schornagel,et al.  Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. , 2002, Archives of otolaryngology--head & neck surgery.

[16]  J. Balter,et al.  IMRT plans robust to setup error and motion: explicit incorporation of clinical setup data using the multiple instance of geometry approximation (MIGA) , 2002 .

[17]  Christopher U. Jones,et al.  Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: preliminary results of a phase II trial of the RTOG (99-14) , 2002 .

[18]  B. Vikram,et al.  Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. , 2002, Seminars in radiation oncology.

[19]  J. Purdy.  Dose-volume specification: new challenges with intensity-modulated radiation therapy. , 2002, Seminars in radiation oncology.

[20]  L. Dawson,et al.  Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[21]  K. Robbins.  Barriers to winning the battle with head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[22]  Benedick A Fraass,et al.  Incorporation of realistic delivery limitations into dynamic MLC treatment delivery. , 2002, Medical physics.

[23]  D L McShan,et al.  Is uniform target dose possible in IMRT plans in the head and neck? , 2002, International journal of radiation oncology, biology, physics.

[24]  M. Puglisi,et al.  Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[25]  A. Rademaker,et al.  Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation , 2002, Head & neck.

[26]  W. Dörr,et al.  Consequential late effects in normal tissues. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  A. Rademaker,et al.  Use of IMRT to reduce toxicity from concomitant radiation and chemotherapy for advanced head and neck cancers , 2001 .

[28]  U. Joos,et al.  Increase of RM3/1‐positive macrophages in radiation‐induced oral mucositis , 2001, The Journal of pathology.

[29]  L. Dawson,et al.  Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Brizel,et al.  Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  V Grégoire,et al.  Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Christopher U. Jones,et al.  Timing of Swallowing Events after Single-Modality Treatment of Head and Neck Carcinomas with Radiotherapy , 2000, The Annals of otology, rhinology, and laryngology.

[33]  A. Dorner,et al.  Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. , 2000, Oral oncology.

[34]  Jonathan G. Li,et al.  Inverse planning incorporating organ motion. , 2000 .

[35]  B. Maciejewski,et al.  Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  A Trotti,et al.  Toxicity in head and neck cancer: a review of trends and issues. , 2000, International journal of radiation oncology, biology, physics.

[37]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[38]  M K Martel,et al.  Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[39]  R. V. Smith,et al.  Pharyngeal transport dysfunction consequent to an organ-sparing protocol. , 1999, Archives of otolaryngology--head & neck surgery.

[40]  Joseph A. Murray,et al.  Manual of Dysphagia Assessment in Adults , 1999 .

[41]  K. Ang,et al.  Altered fractionation: limited by mucosal reactions? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  A. Markoe,et al.  Hyperfractionated radiation therapy and 5‐fluorouracil, cisplatin, and mitomycin‐C (± granulocyte‐colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma , 1997, Cancer.

[43]  J. Fontanesi,et al.  Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. , 1997, International journal of radiation oncology, biology, physics.

[44]  C. Lazarus,et al.  Swallowing Disorders in Head and Neck Cancer Patients Treated With Radiotherapy and Adjuvant Chemotherapy , 1996, The Laryngoscope.

[45]  R. Fisher,et al.  Split-course accelerated therapy in head and neck cancer: an analysis of toxicity. , 1995, International journal of radiation oncology, biology, physics.

[46]  M. Cassell,et al.  Intrinsic fibre architecture and attachments of the human epiglottis and their contributions to the mechanism of deglutition. , 1995, Journal of anatomy.

[47]  S. Mukherji,et al.  Radiologic appearance of the irradiated larynx. Part II. Primary site response. , 1994, Radiology.

[48]  F. McConnel,et al.  Analysis of intrabolus forces in patients with zenker's diverticulum , 1994, The Laryngoscope.

[49]  Lynn J. Romrell.  Sectional Anatomy of the Head and Neck With Correlative Diagnostic Imaging , 1994 .

[50]  P J Kahrilas,et al.  Pharyngeal clearance during swallowing: a combined manometric and videofluoroscopic study. , 1992, Gastroenterology.

[51]  P J Kahrilas,et al.  Closure mechanisms of laryngeal vestibule during swallow. , 1992, The American journal of physiology.

[52]  H. Curtin,et al.  Head and Neck Imaging , 1990 .

[53]  P J Kahrilas,et al.  Upper esophageal sphincter opening and modulation during swallowing. , 1989, Gastroenterology.

[54]  D. Cerenko,et al.  Timing of major events of pharyngeal swallowing. , 1988, Archives of otolaryngology--head & neck surgery.

[55]  C. Sasaki,et al.  Functional anatomy of the larynx. , 1988, Otolaryngologic clinics of North America.

[56]  F. McConnel,et al.  Analysis of pressure generation and bolus transit during pharyngeal swallowing , 1988, The Laryngoscope.

[57]  C. Russell,et al.  Pharyngeal pump and esophageal transit , 1987, Digestive diseases and sciences.

[58]  J. Logemann,et al.  Evaluation and treatment of swallowing disorders , 1984 .

[59]  O. Ekberg,et al.  Movement of the epiglottis during deglutition , 1982, Gastrointestinal Radiology.

[60]  L. Ackerman,et al.  The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron. , 1957, Radiology.

[61]  J Whillis,et al.  Movements of the tongue in swallowing. , 1946, Journal of anatomy.

[62]  Vincent Grégoire,et al.  Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. , 2004, International journal of radiation oncology, biology, physics.

[63]  A. Dietz,et al.  Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[64]  C. Ertekin,et al.  Chapter 19 Physiology and electromyography of swallowing and its disorders , 2000 .

[65]  Jay S. Cooper,et al.  A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .

[66]  A. Kerr,et al.  Scott-Brown's otolaryngology , 1997 .

[67]  I. Cook.  Cricopharyngeal function and dysfunction , 1993, Dysphagia.

[68]  J. Kaanders,et al.  Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. , 1992, International journal of radiation oncology, biology, physics.

[69]  H. Gray.  Gray's Anatomy , 1858 .